4D Molecular Therapeutics, Inc. (FDMT) shares soared 7.9% in the last trading session to close at $10.42. The move was backed by solid volume with far more shares changing hands than in a normal ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

4D Molecular Therapeutics (NASDAQ:FDMT) stock is trading lower on Thursday after the company released interim follow-up data from the Phase 1/2 PRISM clinical trial and 4FRONT Phase 3 study design.

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in MSC Industrial Direct Co Inc (Symbol: MSM), where a total of 4,676 contracts have traded so ...

4D Molecular Therapeutics Inc. Annual stock financials by MarketWatch. View the latest FDMT financial statements, income statements and financial ratios.

4D Molecular Therapeutics, Inc. (FDMT) has been beaten down lately with too much selling pressure. While the stock has lost 26% over the past four weeks, there is light at the end of the tunnel as it ...